Immunology Program
The Michael Glickman Lab
Research

We are broadly interested in the biology of mycobacteria, which include the major human pathogen M. tuberculosis, the nonpathogenic model organism M. smegmatis, and the cancer biotherapeutic agent BCG.
Research Projects

Featured News



People

Michael S. Glickman, MD
- Physician-scientist Michael Glickman investigates the physiology and pathogenic mechanisms of mycobacteria, including the use of mycobacteria as bacterial cancer therapies.
- MD, Columbia University College of Physicians and Surgeons
- [email protected]
- Email Address
- 646-888-2368
- Office Phone
- View physician profile
- Physician profile
Members












Member

Senior Research Scientist

Senior Research Scientist

Assistant Attending Physician

Assistant Lab Member, EIO Cell Bank director

Lab Manager

Research Technician

Fellow

Graduate Student

Graduate Student

Research Scholar

Research Associate

MSK Bridge Program Scholar

Administrative Assistant







Lab Alumni

Graduate Student

Research Fellow

Graduate Student
Research Scholar
Graduate Student

Research Technician

Graduate Student

Senior Research Technician

Graduate Student

Research Fellow

Research Fellow

Postdoctoral Fellow
Technician


Research Technician

Research Associate

ID fellow

Postdoctoral Fellow
Fellow

Research Fellow
Get in Touch
-
Lab Head Email
-
Office Phone
-
Office Fax
-
Lab Phone
-
Lab Fax
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Michael S. Glickman discloses the following relationships and financial interests:
-
Fimbrion Therapeutics, Inc.
Provision of Services -
Opentrons Labworks Inc.
Provision of Services
-
Vedanta
Ownership / Equity Interests; Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].